Women Writers of Ecuador

Abstract

JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.. Board of Regents of the University of Oklahoma and University of Oklahoma are collaborating with JSTOR to digitize, preserve and extend access to Books Abroad.

Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome)

“…This has been postulated to result from circulating endogenous or exogenous toxins in these conditions altering endothelial dysfunction, causing hypoperfusion and vasoconstriction that disrupt the blood-brain barrier. Such was the case in our patient, who developed PRES likely due to using nivolumab as immunotherapy and was normotensive throughout [6][7][8].…”